Literature DB >> 19620290

Repression of ESR1 through actions of estrogen receptor alpha and Sin3A at the proximal promoter.

Stephanie J Ellison-Zelski1, Natalia M Solodin, Elaine T Alarid.   

Abstract

Gene expression results from the coordinated actions of transcription factor proteins and coregulators. Estrogen receptor alpha (ERalpha) is a ligand-activated transcription factor that can both activate and repress the expression of genes. Activation of transcription by estrogen-bound ERalpha has been studied in detail, as has antagonist-induced repression, such as that which occurs by tamoxifen. How estrogen-bound ERalpha represses gene transcription remains unclear. In this report, we identify a new mechanism of estrogen-induced transcriptional repression by using the ERalpha gene, ESR1. Upon estrogen treatment, ERalpha is recruited to two sites on ESR1, one distal (ENH1) and the other at the proximal (A) promoter. Coactivator proteins, namely, p300 and AIB1, are found at both ERalpha-binding sites. However, recruitment of the Sin3A repressor, loss of RNA polymerase II, and changes in histone modifications occur only at the A promoter. Reduction of Sin3A expression by RNA interference specifically inhibits estrogen-induced repression of ESR1. Furthermore, an estrogen-responsive interaction between Sin3A and ERalpha is identified. These data support a model of repression wherein actions of ERalpha and Sin3A at the proximal promoter can overcome activating signals at distal or proximal sites and ultimately decrease gene expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19620290      PMCID: PMC2738295          DOI: 10.1128/MCB.00383-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  74 in total

1.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.

Authors:  X Nan; H H Ng; C A Johnson; C D Laherty; B M Turner; R N Eisenman; A Bird
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

2.  Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells.

Authors:  A Berkenstam; H Glaumann; M Martin; J A Gustafsson; G Norstedt
Journal:  Mol Endocrinol       Date:  1989-01

3.  Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.

Authors:  L D Read; G L Greene; B S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  1989-02

4.  Both positive and negative regulators of HO transcription are required for mother-cell-specific mating-type switching in yeast.

Authors:  K Nasmyth; D Stillman; D Kipling
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

5.  Auto-regulation of the estrogen receptor promoter.

Authors:  C G Castles; S Oesterreich; R Hansen; S A Fuqua
Journal:  J Steroid Biochem Mol Biol       Date:  1997-06       Impact factor: 4.292

6.  Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycle.

Authors:  M F Press; N Nousek-Goebl; W J King; A L Herbst; G L Greene
Journal:  Lab Invest       Date:  1984-11       Impact factor: 5.662

7.  Activation of the yeast HO gene by release from multiple negative controls.

Authors:  P W Sternberg; M J Stern; I Clark; I Herskowitz
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

8.  Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle.

Authors:  C Markopoulos; U Berger; P Wilson; J C Gazet; R C Coombes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-14

9.  Regulation of the estrogen receptor in MCF-7 cells by estradiol.

Authors:  M Saceda; M E Lippman; P Chambon; R L Lindsey; M Ponglikitmongkol; M Puente; M B Martin
Journal:  Mol Endocrinol       Date:  1988-12

10.  The effect of H3K79 dimethylation and H4K20 trimethylation on nucleosome and chromatin structure.

Authors:  Xu Lu; Matthew D Simon; Jayanth V Chodaparambil; Jeffrey C Hansen; Kevan M Shokat; Karolin Luger
Journal:  Nat Struct Mol Biol       Date:  2008-09-14       Impact factor: 15.369

View more
  44 in total

Review 1.  Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1.

Authors:  David K Lung; Rebecca M Reese; Elaine T Alarid
Journal:  Horm Cancer       Date:  2020-06-26       Impact factor: 3.869

2.  Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1.

Authors:  Prashant Rajbhandari; Greg Finn; Natalia M Solodin; Kiran K Singarapu; Sarata C Sahu; John L Markley; Kelley J Kadunc; Stephanie J Ellison-Zelski; Anastasia Kariagina; Sandra Z Haslam; Kun Ping Lu; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

3.  Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway.

Authors:  Shreyas Das; Bryan N Becker; F Michael Hoffmann; Janet E Mertz
Journal:  BMC Cell Biol       Date:  2009-12-21       Impact factor: 4.241

4.  Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation.

Authors:  P Rajbhandari; K A Schalper; N M Solodin; S J Ellison-Zelski; K Ping Lu; D L Rimm; E T Alarid
Journal:  Oncogene       Date:  2013-04-01       Impact factor: 9.867

5.  Streamlining gene expression analysis: integration of co-culture and mRNA purification.

Authors:  Scott M Berry; Chandresh Singh; Jessica D Lang; Lindsay N Strotman; Elaine T Alarid; David J Beebe
Journal:  Integr Biol (Camb)       Date:  2014-02       Impact factor: 2.192

6.  A kinetic model identifies phosphorylated estrogen receptor-α (ERα) as a critical regulator of ERα dynamics in breast cancer.

Authors:  Dan Tian; Natalia M Solodin; Prashant Rajbhandari; Kelsi Bjorklund; Elaine T Alarid; Pamela K Kreeger
Journal:  FASEB J       Date:  2015-02-03       Impact factor: 5.191

7.  Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor.

Authors:  Stephanie J Ellison-Zelski; Elaine T Alarid
Journal:  Mol Cancer       Date:  2010-09-29       Impact factor: 27.401

Review 8.  Sex, epilepsy, and epigenetics.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Neurobiol Dis       Date:  2014-07-04       Impact factor: 5.996

9.  Designer monotransregulators provide a basis for a transcriptional therapy for de novo endocrine-resistant breast cancer.

Authors:  Stephanie L Nott; Yanfang Huang; Aja Kalkanoglu; Kathryn Harper; Ming Chen; Scott F Paoni; Bruce M Fenton; Mesut Muyan
Journal:  Mol Med       Date:  2009-11-17       Impact factor: 6.354

10.  Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer.

Authors:  G L Powers; S J Ellison-Zelski; A J Casa; A V Lee; E T Alarid
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.